NUOPTIMA > Podcast > How Drug Hunter Grew to $2M ARR

How Drug Hunter Grew to $2M ARR

August 7, 2024

Interviewee Introduction: Dennis Hu

This episode features an interview with Dennis, a chemist-turned-founder who launched Drug Hunter, a B2B subscription service for drug discovery professionals. Dennis discusses his academic background, including a fast-tracked PhD from Stanford and work in the biotech industry, before founding Drug Hunter. He shares insights on the initial challenges, such as pricing strategies and deciding on product features, and how the company has grown to serve over 150 institutions with an ARR exceeding 2 million dollars. Key takeaways include the importance of focusing on what customers willing to pay the most demand, and how pivoting from offering consultancy to prioritizing a subscription model was crucial for growth. Additionally, Dennis touches on his journey navigating product development and hiring, along with the impact of organic growth and potential future directions for Drug Hunter.

Start Driving
Revenue
Growth Today

Schedule a free strategy call with one

of our SaaS experts.

  • Ask any questions
  • Learn best strategies for your business
  • Get a no-strings attached quote

Alexej Pikovsky

CEO & Founder

Aman Ghataura

Head of Growth

George Ilic

Head of Clients

Adrijana Palatinus

SEO Lead

Free SEO Book

Get free 279 page practical guide to SEO in 2023

Growth Strategy Call

Book a call with one of our growth experts to discover the best way to grow your business

Contact Us